Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.

our clients
tiltle-brk

client-logo
client-logo2
client-logo3
client-logo4
client-logo
client-logo
client-logo
client-logo

"The quality of representation was outstanding. I never thought that understanding a complex market can be that much easy"

Adam Smith, Associate Director, Bain Capital

"More than just selling a report, the team was more focused towards the understanding of my requirements. Regular updation was the best part."

Koh Vivian, Product Development Manager, Swiss Bio Pharma

"Hats off to expert analysis, the team was very supporting and thanks for not charging me on additional data."

Erin Green, Director, Green Energy Consulting

" I really want to thank Goldstein Research for their efforts to make my project successful. F2F discussion with the market experts was excellent. Keep up the good work guyz "

Jorge Foyo, , Analyst, BCG
Market Research Report

Next Generation Vaccine Market-Key Players, Emerging Trends, Demand, Risk Analysis, Market Size, Share, Scope, Y-O-Y Growth Rate, Opportunity Assessment 2025

Published On : 2018-10-03 Report Page : 350 Category: Healthcare

Global Next Generation Vaccine Market Outlook, 2017-2025

Market Landscape

“Unvaccinatable” targets like HIV and hepatitis C were in the bull’s-eye, for the very first time and traditional vaccine technology (live or inactivated viruses), was unable to provide a viable way to provoke a protective immune response against these diseases. However, considerable amount of potential vaccines in the pipeline tends to change the dynamics of the pharmaceutical business in the future.

Market Segmentation

Next Generation Vaccine Market, By Target Areas

  • Allergy
  • Alzheimer’s Disease
  • Anthrax
  • Asthma
  • Cancer
  • Campylobacter Infection
  • Chlamydia
  • Croup
  • Cytomegalovirus (CMV)
  • Dengue Fever
  • Diabetes
  • Ebola
  • Epstein-Barr Virus
  • Enterotoxigenic Escherichia coli (ETEC)
  • Heart Attack
  • Helicobacter Pylori
  • Hepatitis
  • Herpesvirus
  • Hookworm
  • Hypertension
  • HIV/AIDS
  • Leishmaniasis
  • Malaria
  • MRSA Infection
  • Multiple Sclerosis
  • Obesity
  • Parainfluenza Virus Type 3
  • Parkinson’s Disease
  • Plague
  • Ross River Virus
  • Shigellosis
  • Stroke
  • Tuberculosis
  • West Nile Virus

Market Dynamics (Challenges, Trends & Drivers)

Trends: New vaccine development from the combination of new science (genomics and proteomics), new approaches (DNA vaccines, new combination vaccines, new formulations, novel delivery routes, new adjuvants) and new needs (defence vaccines) for potential use in human medicine is buoyant. In addition, our report covers: DNA Vaccination, Recent Project Terminations, Innovative Delivery Systems, Edible Vaccines, Vaccine Patches, Funding Shortfalls.

Challenges: Viral vectors used for vaccine production are genetically modified organisms (GMOs) and are therefore considered a potential risks to human health and environment associated with the release of these organisms. In order to track the vaccine based projects, European regulatory agencies require environmental risks assessment (ERA) and in USA, the FDA has published guidelines for Environmental Assessments (EA)to evaluate potential environmental and health risks posed by the GMO.       

Drivers: Thinking out of syringe idea has emerged with oral form of the rotavirus vaccine, edible vaccines, mucosally delivered vaccines, intranasal vaccines, patch vaccines and vaccine chips are also all under development for other viruses is driving the global next generation market.

Stagnation in Research Funds Since 2008

HIV vaccine research makes up more than half of all R&D spending on the disease: USD 652 million, or 60 %, in 2014. Malaria vaccine research received a large bump in 2014, increasing its share of R&D funding from USD 120 million to USD 173 million, following several years of declining investment.Several vaccine candidates in clinical development are still at phase II stage, targeting infants and young children, or as potential boosters for the BCG vaccine. Along with HIV and malaria, TB vaccine research has also suffered consecutive declines in funding since the beginning of the decade.

Solution: Sustainable and sufficient funding, coherent investment strategy and support for innovation across the development cycle.

Companies Analyzed

Major players of global Next Generation Vaccine market are Affiris, Alk-Abello A/S, Allergy Therapeutics, AstraZeneca, Bavarian Nordic A/S, Baxter Healthcare, Crucell, Cytos Biotechnology, GlaxoSmithKline, Hawaii Biotech, Merck & Co. Inc, Mymetics, Nabi Biopharmaceuticals, Novartis, Opexa Therapeutics, Sanofi Pasteur.

Following questions answer can be derived from this report:

  • What are the Mortality, Severity and Treatment Availability ratings for all the mentioned target areas in the global next generation vaccine market?
  • Sales estimation of the target market segments.
  • Market estimation for the pipeline vaccines, in addition with the prophylactics vaccine option in the future, successful business model for vaccine, major companies in this market, and possible new entrants
  • Market examination for vaccine manufacturing and production technologies along with focus on current production methods and new methods in development.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements


Next Generation Vaccine Market-Key Players, Emerging Trends, Demand, Risk Analysis, Market Size, Share, Scope, Y-O-Y Growth Rate, Opportunity Assessment 2025

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747